A systems biology analysis of the changes in gene expression via silencing of HPV-18 E1 expression in HeLa cells

Open Biology

Volumn 4, Issue 10, 2014, Pages

  Castillo, Andres ^a,b,d,e   Wang, Lu ^b,c,f   Koriyama, Chihaya ^d   Eizuru, Yoshito ^e   Jordan, King ^b,c,f   Akiba, Suminori ^d  

^a Department of Physiology Basic Sciences School   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d Department of Epidemiology and Preventive Medicine ^*  (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f PanAmerican Bioinformatics Institute   (Colombia)

Author keywords

EP300 protein; HeLa cells; HPV E1 protein; Human papillomavirus; Microarrays analysis; SiRNAs

Indexed keywords

HUMAN PAPILLOMAVIRUS;

ONCOGENE PROTEIN E1, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HELA CELL LINE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS; SYSTEMS BIOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; UTERINE CERVIX TUMOR; VIROLOGY;

APOPTOSIS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HELA CELLS; HUMAN PAPILLOMAVIRUS 18; HUMANS; ONCOGENE PROTEINS, VIRAL; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, RNA; SYSTEMS BIOLOGY; TRANSCRIPTIONAL ACTIVATION; UTERINE CERVICAL NEOPLASMS;

EID: 84923683630     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.130119     Document Type: Article

References (44)

1. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi FE. 2005 Carcinogenicity of human papillomaviruses. Lancet Oncol. 6, 204. (doi:10. 1016/S1470-2045(05)70086-3)
2. Gillison ML, Shah KV. 2003 Chapter 9: role of mucosal human papillomavirus in nongenital cancers. JNCI Monogr. 2003, 57-65. (doi:10.1093/ oxfordjournals.jncimonographs.a003484)
3. Castillo A et al . 2011 Human papillomavirus in upper digestive tract tumors from three countries. World J. Gastroenterol. 17, 5295-5304. (doi:10. 3748/wjg.v17.i48.5295)
4. Castillo A et al . 2006 Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J. Gastroenterol. 12, 6188-6192.
5. Castillo A et al. 2006 Human papillomavirus in lung carcinomas among three Latin American countries. Oncol. Rep. 15, 883-888.
6. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. 1984 A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3, 1151-1157.
7. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H. 1985 Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114. (doi:10.1038/314111a0)
8. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. 1985 Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119, 361-366.
9. Pater MM, Pater A. 1985 Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145, 313-318. (doi:10.1016/ 0042-6822(85)90164-3)
10. Schneider-Gadicke A, Schwarz E. 1986 Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5, 2285-2292.
11. Seedorf K, Oltersdorf T, Krammer G, Rowekamp W.1987 Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J. 6, 139-144.
12. Inagaki Y, Tsunokawa Y, Takebe N, Nawa H, Nakanishi S, Terada M, Sugimura T. 1988 Nucleotide sequences of cDNAs for human papillomavirus type 18 transcripts in HeLa cells. J. Virol. 62, 1640-1646.
13. Meissner JD. 1999 Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80, 1725-1733.
14. Lin BY, Ma T, Liu J-S, Kuo S-R, Jin G, Broker TR, Harper JW, Chow LT. 2000 HeLa cells are phenotypically limiting in cyclin E/CDK2 for efficient human papillomavirus DNA replication. J. Biol. Chem. 275, 6167-6174. (doi:10.1074/jbc.275.9. 6167)
15. zur Hausen H. 2002 Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342-350. (doi:10.1038/nrc798)
16. Park P, Copeland W, Yang L, Wang T, Botchan MR, Mohr IJ. 1994 The cellular DNA polymerase alphaprimase is required for papillomavirus DNA replication and associates with the viral E1 helicase. Proc. Natl Acad. Sci. USA 91, 8700-8704. (doi:10. 1073/pnas.91.18.8700)
17. Loo Y-M, Melendy T. 2004 Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNA. J. Virol. 78, 1605-1615. (doi:10.1128/JVI.78.4. 1605-1615.2004)
18. Clower RV, Fisk JC, Melendy T. 2006 Papillomavirus E1 protein binds to and stimulates human topoisomerase I. J. Virol. 80, 1584-1587. (doi:10. 1128/JVI.80.3.1584-1587.2006)
19. Liu J-S, Kuo S-R, Makhov AM, Cyr DM, Griffith JD, Broker TR, Chow LT. 1998 Human Hsp70 and Hsp40 chaperone proteins facilitate human papillomavirus-11 E1 protein binding to the origin and stimulate cell-free DNA replication. J. Biol. Chem. 273, 30 704-30 712. (doi:10.1074/jbc.273.46.30704)
20. Cô té -Martin A et al. 2008 Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to Integrative genomics viewer (IGV): highrsob. promote maintenance of the viral genome in keratinocytes. J. Virol. 82, 1271-1283. (doi:10. 1128/JVI.01405-07)
21. Ma T, Zou N, Lin BY, Chow LT, Harper JW. 1999 Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc. Natl Acad. Sci. USA 96, 382-387. (doi:10.1073/pnas.96. 2.382)
22. Swindle CS, Engler JA. 1998 Association of the human papillomavirus type 11 E1 protein with histone H1. J. Virol. 72, 1994-2001.
23. Lee D, Sohn H, Kalpana GV, Choe J, Choe J. 1999 Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 399, 487-491. (doi:10.1038/20966)
24. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, Saigo K. 2004 Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32, 936-948. (doi:10.1093/nar/gkh247)
25. Naito Y, Yamada T, Ui-Tei K, Morishita S, Saigo K. 2004 siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res. 32, W124-W129. (doi:10.1093/ nar/gkh442)
26. Pfaffl MW. 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, 45e. (doi:10.1093/nar/29.9.e45)
27. Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, Paabo S, Mann M. 2011 Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548. (doi:10.1038/msb.2011.81)
28. Langmead B, Salzberg SL. 2012 Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359. (doi:10.1038/nmeth.1923)
29. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011 Integrative genomics viewer. Nat. Biotechnol. 29, 24-26. (doi:10.1038/nbt.1754)
30. Thorvaldsdottir H, Robinson JT, Mesirov JP. 2013 performance genomics data visualization and exploration. Brief. Bioinform. 14, 178-192. (doi:10. 1093/bib/bbs017)
31. Schoggins JW, Rice CM. 2011 Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519-525. (doi:10.1016/j.coviro.2011. 10.008)
32. Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, Srivastava S, Mittal B. 2009 Impact of Toll-like receptors [TLR] 2 (2 196 to 2 174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol. Oncol. 114, 501-505. (doi:10.1016/j.ygyno.2009.05.032)
33. Cheng YX, Qi XY, Huang JL, Hu M, Zhou LM, Li BS, Xu XX. 2012 Toll-like receptor 4 signaling promotes the immunosuppressive cytokine production of human cervical cancer. Eur. J. Gynaecol. Oncol. 33, 291-294.
34. Petricoin E, David M, Fang H, Grimley P, Larner AC, Vande Pol S. 1994 Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins. Mol. Cell. Biol. 14, 1477-1486.
35. Lace MJ, Anson JR, Haugen TH, Turek LP. 2010 Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes. Virology 399, 270-279. (doi:10.1016/j.virol.2009.12.025)
36. Stanley MA, Pett MR, Coleman N. 2007 HPV: from infection to cancer. Biochem. Soc. Trans. 35, 1456-1460. (doi:10.1042/BST0351456)
37. Ramos MC, Mardegan MC, Tirone NR, Michelin MA, Murta EFC. 2010 The clinical use of type 1 interferon in gynecology. Eur. J. Gynaecol. Oncol. 31, 145-150.
38. Ghosh AK, Varga J. 2007 The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J. Cell. Physiol. 213, 663-671. (doi:10.1002/jcp.21162)
39. Yu J, de Belle I, Liang H, Adamson ED. 2004 Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol. Cell 15, 83-94. (doi:10.1016/j.molcel.2004.06.030)
40. Huang W-C, Chen C-C. 2005 Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol. Cell. Biol. 25, 6592-6602. (doi:10.1128/MCB.25.15. 6592-6602.2005)
41. Chen J, Halappanavar SS, St-Germain JR, Tsang BK, Li Q. 2004 Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cell. Mol. Life Sci. 61, 1675-1683. (doi:10.1007/s00018-004-4103-9)
42. Saegusa M, Hashimura M, Kuwata T, Hamano M, Watanabe J, Kawaguchi M, Okayasu I. 2008 Transcription factor Egr1 acts as an upstream regulator of b-catenin signalling through upregulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells. J. Pathol. 216, 521-532. (doi:10.1002/path.2404)
43. Akutagawa O, Nishi H, Kyo S, Terauchi F, Yamazawa K, Higuma C, Inoue M, Isaka K. 2008 Early growth response-1 mediates downregulation of telomerase in cervical cancer. Cancer Sci. 99, 1401-1406. (doi:10.1111/j.1349-7006.2008.00835.x)
44. Bouallaga I, Teissier S, Yaniv M, Thierry F. 2003 HMGI (Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity. Mol. Cell. Biol. 23, 2329-2340. (doi:10.1128/MCB.23.7.2329-2340.2003)